Drug Type Small molecule drug |
Synonyms- |
Mechanism mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization Epics Therapeutics SAStartup |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | - | - | |
Asthma | Phase 1 | - | - | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | - | - | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | - | - | |
Neoplasms | Preclinical | BE | Epics Therapeutics SAStartup | 04 Apr 2023 |